Effects of methylprednisolone infusions on vital signs in children with headaches
Elaine Heidrich1, Gail Greene, Jessica Weberding
1Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Insights
Pediatric patients receiving intravenous methylprednisolone (IVMP) experienced significant vital sign fluctuations. This highlights the need for standardized monitoring guidelines to ensure patient safety during IVMP infusions.
Area of Science:
- Pediatric pharmacology
- Cardiovascular monitoring
- Patient safety
Background:
- Intravenous methylprednisolone (IVMP) infusions are linked to adverse cardiovascular effects.
- Inconsistent monitoring practices in pediatric settings raise patient safety concerns.
- This study addresses vital sign changes and monitoring during IVMP in children.
Purpose of the Study:
- To describe vital sign changes in pediatric patients receiving IVMP.
- To evaluate monitoring practices associated with IVMP infusions.
- To inform the development of standardized monitoring guidelines.
Main Methods:
- Retrospective chart review of 74 pediatric patients (ages 5-17) receiving IVMP.
- Data collection included blood pressure, heart rate, IVMP dosage, and timing.
- Analysis of ordered vs. performed vital sign monitoring frequency.
Main Results:
- Half of patients had abnormal vital signs at baseline.
- A majority experienced >10% vital sign changes after the first IVMP dose.
- Vital sign changes occurred up to 135.5 hours post-dose, more in older children and with higher doses.
Conclusions:
- Pediatric patients exhibit significant vital sign fluctuations during IVMP therapy.
- Current monitoring practices are inconsistent and may require standardization.
- Prospective studies are needed to establish IVMP-specific monitoring guidelines.
Objectives:
Intravenous methylprednisolone (IVMP) infusions have been associated with adverse cardiovascular effects. Inconsistent monitoring practices in a pediatric hospital led to questions about patient safety and allocation of nursing resources. This study describes vital sign changes in children and monitoring practices related to IVMP.
Methods:
This retrospective chart review received Institutional Review Board approval. Children aged 5 to 17 years receiving IVMP from January 2006 to January 2009 were included. Seventy-four patients with 94 hospital admissions were evaluated. Data collected included systolic blood pressure, diastolic blood pressure, and heart rate, as well as the time and dosage of IVMP. Frequency of vital sign monitoring as ordered and as performed was described. Interrater reliability was calculated, and descriptive statistics were used in the data analysis.
Results:
At baseline, about half of the patients had vital signs out of normal range for age. After the first dose, vital signs fluctuated, with a majority having greater than 10% changes from baseline as increases, decreases, or both. Time of initial 10% change in vital signs ranged from immediately after the dose to 135.5 hours later. Increased vital sign changes were seen in the older patients and in patients receiving higher doses. Monitoring of vital signs occurred more frequently than was ordered. Only 1 patient had a specific order for monitoring with IVMP.
Conclusions:
The patients included in this study experienced documented fluctuations in vital signs. A prospective study to evaluate the relationship of IVMP and patient safety will assist in standardizing vital sign monitoring guidelines.
Related Concept Videos
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Increased Intracranial Pressure l: Introduction
Drug Dosing: Infants and Children
Parenteral Anesthetics: Overview
Decreased Body Temperature

